Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

NCT02075177 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

NETWORK

Sponsor class

Conditions

Recurrent Neuroblastoma
Neuroblastoma

Interventions

DRUG: Fenretinide Lym-X-Sorb Oral Powder
DRUG: Ketoconazole

Sponsor

South Plains Oncology Consortium